Lymphoma of the ocular adnexa

Akpek EK, Ahmed I, Hochberg FH, Soheilian M, Dryja TP, Jakobiec FA, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology. 1999;106:1805-10.

Meunier J, Lumbroso-Le Rouic L, Vincent-Salomon A, Dendale R, Asselain B, Arnaud P, et al. Ophthalmologic and intraocular non-Hodgkin’s lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors. Hematol Oncol. 2004;22:143-58.

Buggage RR, Chan CC, Nussenblatt RB. Ocular manifestations of central nervous system lymphoma. Curr Opin Oncol. 2001;13:137-

Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control. 2004;11:285-95.

Plotkin SR, Batchelor TT. Advances in the therapy of primary central nervous system lymphoma. Clin Lymphoma. 2001;1:263-

Uno T, Isobe K, Shikama N, Nishikawa A, Oguchi M, Ueno N, et al. Radiotherapy for extranodal, marginal-zone, B-cell lymphoma

of mucosa-associated lymphoid tissue originating in the ocular adnexa. Cancer. 2003;98:865-71.

Nuckel H, Meller D, Steuhl KP, Duhrsen U. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.

Eur J Haematol. 2004;73:258-62.

Zinzani PL, Alinari L, Stefoni V, Loffredo A, Pichierri P, Polito E. Rituximab in primary conjunctiva lymphoma. Leuk Res. 2005;

:107-8.

Didier Decaudin, Patricia de Cremoux, Anne Vincent-Salomon, Remi Dendale, Livia Lumbroso-Le Rouic. Ocular adnexal lymphoma:

a review of clinicopathologic features and treatment options. Blood. 2006;108:1451-60.

Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21:4157-64.

Liao SL, Kao SC, Hou PK, Chen MS. Results of radiotherapy for orbital and adnexal lymphoma. Orbit. 2002;21:117-23.

Chanissara Pratchayaprateep, Pimjai Niparuck, Paisarn Boonsakan. Lymphoma of the ocular adnexa: a retrospective study in a tertiary care center. J Hematol Transfus Med. 2022;32:35-43.